AGVHD PROPHYLAXIS

Clinical trials for AGVHD PROPHYLAXIS explained in plain language.

Never miss a new study

Get alerted when new AGVHD PROPHYLAXIS trials appear

Sign up with your email to follow new studies for AGVHD PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to prevent dangerous transplant complication in rare blood cancer

Disease control Not yet recruiting

This study tests whether a new drug called gecacitinib, combined with standard anti-rejection medicine, can prevent a serious complication called graft-versus-host disease (GVHD) in people with myelofibrosis who receive a stem cell transplant. About 40 adults will take part. The …

Matched conditions: AGVHD PROPHYLAXIS

Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC

AGVHD PROPHYLAXIS

Get alerted when new AGVHD PROPHYLAXIS trials appear

New drug combo aims to prevent dangerous transplant complication in rare blood cancer